Sildenafil Citrate Tablet, Film Coated
Product Images NDC 71205-623

9 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 71205-623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-623-90 (Sildenafil Tablets Usp 20mg 1000 Label)

71205-623-90 (Sildenafil Tablets Usp 20mg 1000 Label)
Sildenafil 20 mg tablets film-coated label from Proficient Rx LP. The label states 90 tablets per bottle and includes details such as the product ID SS062390 and manufacturer Rubicon Research Private Limited, India. The tablets are described as white, round, biconvex, and debossed with R on one side and 20 on the other. Storage instructions specify 20-25°C (68-77°F). The label features the NDC 71205-623-90 and a QR code, along with relabeler information from Proficient Rx LP in Thousand Oaks, CA.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

Graph (Sildenafil Tablets Usp 20mg Figure 06)
A Kaplan-Meier survival curve chart showing estimated cumulative mortality rate (%) over time (years) for three dose groups: High Dose, Medium Dose, and Low Dose. The chart includes the number at risk for each group at various time points up to 5 years, with High Dose having the highest cumulative mortality rate, followed by Medium Dose, and Low Dose showing the lowest.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

Graph (Sildenafil Tablets Usp 20mg Figure 07)
A forest plot chart showing fold changes and 90% confidence intervals of pharmacokinetic parameters (AUC and Cmax) for sildenafil when coadministered with various interacting drugs, including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. The chart also includes dosing adjustment recommendations based on the interactions.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

Graph (Sildenafil Tablets Usp 20mg Figure 08)
A forest plot chart depicting the fold change and 90% confidence intervals for various interacting drugs relative to the interacting drug alone. The chart lists drugs such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin variants, Ethinyloestradiol, Levonorgestrel, Phentprocoumon, Ritonavir, Saquinavir, and Tolbutamide, with corresponding fold changes and recommendations for dose adjustment, mostly indicating no dose adjustment except for Ritonavir where coadministration is not recommended. The x-axis shows change relative to interacting drug alone, ranging from 0.5 to 2.0.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

Graph (Sildenafil Tablets Usp 20mg Figure 09)
A line graph showing change from baseline (in meters) over weeks 4, 8, and 12 of study for four groups: Placebo, Sildenafil 20 mg TID, Sildenafil 40 mg TID, and Sildenafil 80 mg TID. The y-axis measures change from baseline distance, and the x-axis indicates study weeks. Error bars represent variability around each data point.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

Graph (Sildenafil Tablets Usp 20mg Figure 10)
A forest plot illustrating the placebo-corrected change in 6-minute walk distance (meters) for Sildenafil 20 mg TID across various subgroups. Subgroups include baseline walk distance, PAH etiology, PH functional class, gender, age, mean PAP, and PVRI. The plot shows mean effects with confidence intervals for each subgroup comparison.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

Graph (Sildenafil Tablets Usp 20mg Figure 11)
A Kaplan-Meier curve comparing the percentage of subjects without a clinically worsening event over time (days from randomization) between a placebo group and a sildenafil group. The graph shows higher event-free percentages in the sildenafil group compared to the placebo group throughout the study period.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

Graph (Sildenafil Tablets Usp 20mg Figure 12)
A line graph showing mean change from baseline in meters over 12 weeks for Sildenafil doses 1 mg TID, 5 mg TID, and 20 mg TID. The y-axis shows change from baseline values, and the x-axis depicts weeks 4, 8, and 12. Error bars indicate standard error for each treatment at each visit.*
FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

Structure Formula (Sildenafil Tablets Usp 20mg Structure)
Chemical structure of Sildenafil, the active ingredient in Sildenafil Citrate 20 mg oral film-coated tablets by Proficient Rx LP. The diagram shows the molecular arrangement of atoms within the sildenafil molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.